Luigi Notarangelo
Overview
Explore the profile of Luigi Notarangelo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tometten I, Felgentreff K, Honig M, Hauck F, Albert M, Niehues T, et al.
Clin Immunol
. 2019 Feb;
201:30-34.
PMID: 30776520
Severe combined immunodeficiencies (SCID) comprise a group of genetic diseases characterized by abrogated development of T lymphocytes. In some case reports of atypical SCID patients elevated proportions of γδ T...
12.
Kohler S, Carmody L, Vasilevsky N, Jacobsen J, Danis D, Gourdine J, et al.
Nucleic Acids Res
. 2018 Nov;
47(D1):D1018-D1027.
PMID: 30476213
The Human Phenotype Ontology (HPO)-a standardized vocabulary of phenotypic abnormalities associated with 7000+ diseases-is used by thousands of researchers, clinicians, informaticians and electronic health record systems around the world. Its...
13.
Dvorak C, Haddad E, Buckley R, Cowan M, Logan B, Griffith L, et al.
J Allergy Clin Immunol
. 2018 Sep;
143(1):405-407.
PMID: 30193840
No abstract available.
14.
Hickstein D, Notarangelo L
Blood
. 2017 Sep;
130(12):1391-1393.
PMID: 28935643
No abstract available.
15.
Heimall J, Buckley R, Puck J, Fleisher T, Gennery A, Haddad E, et al.
Biol Blood Marrow Transplant
. 2017 May;
23(8):1229-1240.
PMID: 28479164
Severe combined immunodeficiency (SCID) is effectively treated with hematopoietic cell transplantation (HCT), with overall survival approaching 90% in contemporary reports. However, survivors are at risk for developing late complications because...
16.
Dietz A, Duncan C, Alter B, Bresters D, Cowan M, Notarangelo L, et al.
Biol Blood Marrow Transplant
. 2016 Oct;
23(1):24-29.
PMID: 27737772
An international consensus conference sponsored by the Pediatric Blood and Marrow Transplant consortium entitled "Late Effects Screening and Recommendations Following Allogeneic Hematopoietic Cell Transplant for Immune Deficiency and Nonmalignant Hematologic...
17.
Speckmann C, Doerken S, Aiuti A, Albert M, Al-Herz W, Allende L, et al.
J Allergy Clin Immunol
. 2016 Sep;
139(4):1302-1310.e4.
PMID: 27658761
Background: Absent T-cell immunity resulting in life-threatening infections provides a clear rationale for hematopoetic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency (SCID). Combined immunodeficiencies (CIDs) and "atypical"...
18.
Cabral-Marques O, Ramos R, Schimke L, Khan T, Amaral E, Barbosa Bomfim C, et al.
J Allergy Clin Immunol
. 2016 Aug;
139(3):900-912.e7.
PMID: 27554817
Background: CD40 ligand (CD40L) deficiency predisposes to opportunistic infections, including those caused by fungi and intracellular bacteria. Studies of CD40L-deficient patients reveal the critical role of CD40L-CD40 interaction for the...
19.
John T, Walter J, Schuetz C, Chen K, Abraham R, Bonfim C, et al.
J Clin Immunol
. 2016 Aug;
36(7):725-32.
PMID: 27539235
The use of HLA-identical hematopoietic stem cell transplantation (HSCT) demonstrates overall survival rates greater than 75 % for T-B-NK+ severe combined immunodeficiency secondary to pathogenic mutation of recombinase activating genes...
20.
Kammermeier J, Lucchini G, Pai S, Worth A, Rampling D, Amrolia P, et al.
Blood
. 2016 Jul;
128(9):1306-8.
PMID: 27418642
No abstract available.